N501Y : Science VIEWERS only thanks!

New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found

in two easier-to-spread variants of the coronavirus that erupted in Britain and South Africa.

They used blood samples from 20 people who received the vaccine

made by Pfizer and its German partner BioNTech

during a large study of the shots.

Antibodies from those vaccine recipients successfully fended off the virus in lab dishes

according to the study posted late Thursday on an online site for researchers.

Called N501Y, it is a slight alteration on one spot of the spike protein that coats the virus.

www.biorxiv.org/content/10.1101/2021.01.07.425740v1

Science only, Please !

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine

Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom and South Africa

share the spike N501Y substitution, which is of particular concern because it is located

in the viral receptor binding site for cell entry

and increases binding to the receptor (angiotensin converting enzyme 2).

We generated isogenic N501 and Y501 SARS-CoV-2. Sera

of 20 participants in a previously reported trial of the mRNA-based COVID-19 vaccine

BNT162b2 had equivalent neutralizing titers to the N501 and Y501 viruses.

A similar vaccine by Moderna is being rolled out in the U.S. and Europe, and on Friday was cleared in Britain.

Moderna is doing similar testing to tell if its shot also works against the variants

as are makers of other types of COVID-19 vaccines.

British scientists have said the variant found in the U.K.

– which has become the dominant type in parts of England

-- still seemed to be susceptible to vaccines.

That mutant has now been found in the U.S. and numerous other countries.

Mapoui has to wait until his HANDLERS post a LINK

then he will open some silly thread from a Non Scientist.

typical modus operandi of a Conspiracy Theorist ......hahahahahaha